ARCHIVES

NTP Board Okays Modification Of Bioassay Protocols

This article is from The Cancer Letter archive.

Vol. 08 No. 15 | April 9, 1982

Download PDF Visit The Full Archive

Related Articles

Oncologists Tell Congress Community Cancer Practices Are Not Adequately Reimbursed

April 4, 2014

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

April 27, 2012

Sequestration Hurts Kids with Cancer

March 15, 2013

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

CMS To Recognize NCCN’s Drug Compendium.

June 6, 2008